Hello Heart is the only digital therapeutics company to focus exclusively on heart disease, the leading cause of death worldwide. Through a connected mobile device that uses AI, behavioral science, and personalized digital coaching to drive lifestyle changes, Hello Heart empowers people to reduce blood pressure and predicts serious heart issues before they occur. Validated in peer-reviewed studies, Hello Heart is easy to use and works alongside an employer’s benefits ecosystem. Leading employers across most major industries are realizing immediate and sustained results for member engagement, clinical outcomes, and reduced cost of unnecessary cardiac procedures. Founded in 2013, Hello Heart is a member of the American Heart Association’s Innovators’ Network and is part of the CVS Health Point Solutions Management Program. Visit www.helloheart.com for more information.
Additionally, here's a link to the video with a product tour: https://go.helloheart.com/ProductTour.
Digital Healthcare Guidance – Hypertension and Heart Disease
Region 14 ESC
3 year term, April 19, 2022 to April 30, 2025
*Option to renew for two (2) additional one (1) year periods.
Request for Proposal:
RFP for Digital Healthcare Guidance – Hypertension and Heart Disease
Awarded Vendor Response:
Hello Heart's Response to RFP
Bid Tab & Request for RFP List
Region 14 Award Letter
USA Today Ad 1
USA Today Ad 2
NCPA Website Ad
VP Sales - Public Sector